Fusmobile
2 known investors
FUS Mobile develops the Neurolyser XR, a non-invasive, fluoroscopy-guided ablative therapy platform for treating chronic low back pain caused by arthritis of the vertebral facet joints. The medical device targets patients and physicians as an alternative to invasive standard-of-care procedures.
HardwareHealthtechMedical Devices
Investors Β· 2
Frequently asked questions
- What does Fusmobile do?
- FUS Mobile develops the Neurolyser XR, a non-invasive, fluoroscopy-guided ablative therapy platform for treating chronic low back pain caused by arthritis of the vertebral facet joints. The medical device targets patients and physicians as an alternative to invasive standard-of-care procedures.
- Who are Fusmobile's investors?
- Fusmobile's investors include Atlanta Technology Angels, OrbiMed.